Trial
NCT01420861
GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
GTx
Collaborators
—
Condition
Prostate Cancer
Intervention
GTx-758
Why stopped
FDA Clinical Hold
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-06